Home Stock

Stock Research: AtriCure

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

AtriCure

NasdaqGM:ATRC US04963C2098
77
  • Value
    50
  • Growth
    85
  • Safety
    Safety
    52
  • Combined
    82
  • Sentiment
    68
  • 360° View
    360° View
    77
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

AtriCure, Inc. provides technologies for treating atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management. The company operates in the medical device industry. AtriCure's products are used in open-heart and minimally invasive surgical procedures. In the last fiscal year, the company had a market cap of $1,514 million, profits of $348 million, and revenue of $465 million, with 1300 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 77 (better than 77% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock AtriCure are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for AtriCure. The consolidated Value Rank has an attractive rank of 52, which means that the share price of AtriCure is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 52% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 85, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 50. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 68. ...read more

more
Country USA
Industry Health Care Equipment
Size Small
Website atricure.com
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
52 37 38 17
Growth
85 73 79 85
Safety
Safety
50 67 20 11
Sentiment
68 94 73 56
360° View
360° View
77 98 60 24
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
95 97 59 4
Opinions Change
97 77 50 30
Pro Holdings
n/a 73 55 100
Market Pulse
35 71 87 75
Sentiment
68 94 73 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
52 37 38 17
Growth
85 73 79 85
Safety Safety
50 67 20 11
Combined
82 72 32 22
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
56 56 56 26
Price vs. Earnings (P/E)
56 40 45 25
Price vs. Book (P/B)
48 46 55 43
Dividend Yield
1 1 1 1
Value
52 37 38 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
69 64 61 59
Profit Growth
92 48 79 98
Capital Growth
76 64 86 41
Stock Returns
55 71 35 77
Growth
85 73 79 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
76 75 58 53
Refinancing
41 34 21 13
Liquidity
24 51 40 34
Safety Safety
50 67 20 11

Similar Stocks

Discover high‑ranked alternatives to AtriCure and broaden your portfolio horizons.

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis
OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.